Abstract
Administration of the serotonin agonist m-chlorophenylpiperazine to rats produced a dose-related hyperthermia. Pretreatment with the serotonin receptor antagonist metergoline totally abolished this response, whereas similar treatment with haloperidol, phenoxybenzamine, naloxone, clonidine, pindolol, propranolol, methiotepin, and ritanserin was ineffective. In studies investigating the modification of the response by antidepressant treatments both acute (3 day) and chronic (22 day) administration of the MAO inhibitor clorgyline, as well as the tricyclics clomipramine and imipramine, attenuated the hyperthermic response to m-CPP. These findings are discussed with regard to the specificity of m-CPP-induced hyperthermia and its subsequent modification by antidepressant treatments, in order to evaluate this model's use as a probe for assessment of the serotonergic system.
Similar content being viewed by others
References
Aloi JA, Insel TR, Mueller EA, Murphy DL (1984) Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci 34:1325–1331
Aulakh CS, Cohen RM, Hill JL, Murphy DL, Zohar J (1987) Long term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats. Br J Pharmacol 81:747–752
Bagdy G, Szemeredi K, Zukowska-Grojec Z, Hill J, Murphy DL (1987) m-Chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious rats. Life Sci 41:775–782
Brazenor RW, Augus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576
Caccia S, Ballabio M, Samanin R (1981) (−)-m-Chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477–478
Caccia S, Fong MH, Garattinis V, Zanini MG (1982) Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone. J Pharm Pharmacol 34:605–606
Charney DS, Menkes DB, Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment: implications for the etiology and treatment of depression. Arch Gen Psychiatry 88:1160–1180
Cohen ML, Fuller RW (1983) Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine. Life Sci 32:711–718
Cohen RM, Aulakh CS, Murphy DL (1983) Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine. Eur J Pharmacol 94:175–179
Colpaert FC, Leysen JE (1981) Characterization of in vivo agonist and antagonist activity of purported 5-hydroxytryptamine antagonists and of R 47 465, and LSD antagonist. In: Abstracts of the Eighth International Congress of Pharmacology, IU-PHAR, Tokyo, Japan, p 595
Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J Pharmacol Exp Ther 552–557
Fuller RW, Snoddy HD, Mason NR, Owen JE (1981) Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology 20:155–162
Fuxe K, Agnati L, Everitt B (1975) Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors. Neurosci Lett 1:283–290
Fuxe K, Ogren SO, Agnati LF, Calza L (1982) Evidence for stabilization of cortical 5-HT neurotransmission by chronic treatment with antidepressant drugs: induction of a high and low affinity component in 3H-5-HT binding sites. Acta Physiol Scand 114:477–480
Fuxe K, Ogren S-O, Agnati LF, Benfenati F, Fredholm B, Andersson K, Zini I, Eneroth P (1983) Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology 22:389–400
Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753
Goodwin GM, DeSouza RJ, Green AR, Heal DJ (1987) The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 91:506–511
Gothert M (1982) Modulation of serotonin release into the brain via presynaptic receptors. TIPS 3:437–440
Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 25:1307–1313
Hall H, Ogren SO (1981) Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 70:393–407
Hamon M, Cossery JM, Spampinato V, Gozlan H (1986) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain. TIPS 7:336–338
Hjorth S (1985) Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J Neural Transm 61:131–135
Hjorth S, Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin receptors? Eur J Pharmacol 129:131–138
Invernizzi R, Cotecchia S, DeBlasi A, Mennini T, Pataccini R, Samanin R (1981) Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239–244
Kalkman HO, Timmermans PSMWM, Van Zwieten PA (1982) Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J Pharmacol Exp Ther 222:227–231
Kendall DA, Nahorski SR (1984) Suppression of 5-HT receptor mediated inositol phospholipid breakdown in brain by chronic antidepressant treatment. Br J Pharmacol 82:206P
Kendall DA, Duman R, Slopis J, Enna SJ (1982) Influence of adrenocorticotrophin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function. J Pharmacol Exp Ther 22:566–571
Knoll J (1976) Analysis of the pharmacological aspects of selective monoamine oxidase inhibitors. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and its inhibition. Elsevier, Amsterdam, pp 135–161
Kruk ZL (1972) The effect of drugs acting on dopamine receptors on the body temperature of the rat. Life Sci 11:845–850
Leysen J (1984) Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 23:247–254
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PA (1981) Receptor binding profile of R41-468 a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611
Lucki I, Frazer A (1982) Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology 77:205–211
Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98
Maj J, Lewandowska A (1980) Central serotoninmimetic action of phenylpiperazine. Pol J Pharmacol Pharm 32:495–504
Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn Schmiedeberg's Arch Pharmacol 321:165–170
Mawson C, Whittington H (1970) Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol 39:223P
Meltzer HY, Simonovic M, Gudelsky GA (1983) Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. Eur J Pharmacol 92:83–89
Melzacka M, Boksa J, Maj J (1979) 1-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urine. J Pharm Pharmacol 31:855–856
Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects of m-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179–1184
Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388–391
Ogren SO, Fuxe K, Agnati LF, Gustafsson JA, Jonsson G, Holm AC (1979) Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 46:85–103
Olpe HR (1981) Differential effect of chlorimipramine and clorgyline on the sensitivity of cortical neurons to serotonin. Eur J Pharmacol 69:375–377
Pawlowski L (1984) Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats. J Pharm Pharmacol 36:197–199
Persson B, Hedner T, Henning M (1982) Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol 34:442–445
Peroutka SJ, Snyder SH (1980) Long term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210:88–90
Pettibone DJ, Williams M (1984) Serotonin-releasing effects of substituted piperazines in vitro. Biochem Pharmacol 33:1531–1535
Quattrone A, Schettini G, Annunziato L, Di Renzo G (1981) Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur J Pharmacol 76:9–13
Rowan MJ, Anwyl R (1985) The effect of prolonged treatment with tricyclic antidepressants on the actions of 5-hydroxytryptamine in the hippocampal slice of the rat. Neuropharmacology 24:131–137
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F (1980) Hyper- and hyposensitivity of central serotonin receptors: 3H-serotonin binding and functional studies in the rat. Brain Res 189:449–457
Savage DD, Mendels J, Frazer A (1980) Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. J Pharmacol Exp Ther 212:259–263
Segawa T, Mizuta T, Nomura Y (1979) Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants. Eur J Pharmacol 58:75–83
Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487
Stolz JF, Marsden CA, Middlemiss DN (1983) Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology 80:150–155
Tang SW, Seeman P (1980) Effect of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 311:255–261
Willner P (1985) Antidepressant and serotonergic neurotransmission: an integrative review. Psychopharmacology 85:387–404
Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30:451–456
Yang H-Y, Neff NH (1974) The monoamine oxidases of brain: selective inhibition with drugs and the consequence for the metabolism of the biogenic amines. J Pharmacol Exp Ther 189:733–740
Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988) Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry 45:167–172
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wozniak, K.M., Aulakh, C.S., Hill, J.L. et al. Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology 97, 269–274 (1989). https://doi.org/10.1007/BF00442262
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442262